Immunai

[Not Yet Scheduled]
Immunai is a biotech company mapping the immune system at unprecedented scale & granularity to develop the next-generation of immunomodulatory therapeutics. Our therapeutics engine is built on an integrated immune data platform (AMICA) that combines multi-omic single cell analysis with machine learning and functional genomics to integrate translational disease biology with causal immune insights.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
New York
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
N/A
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
co-Founder and CEO
ImmunAI